Aminoglycosides Market
According to Intent Market Research, the Aminoglycosides Market is expected to grow from USD 4.0 billion in 2023 at a CAGR of 7.1% to touch USD 6.4 billion by 2030. The Aminoglycosides Market is dominated by key players such as AbbVie Inc., Aurobindo Pharma, Bayer AG, Bristol-Myers Squibb Company, Fresenius Kabi AG, GSK (GlaxoSmithKline plc), Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer Inc., Sanofi S.A. and Zydus Cadila.